• Oncuria®, Multiplex Biomarker Immunoassay for Bladder Cancer, Urine
  • B-Type Natriuretic Peptide (BNP) or Pro B-Type Natriuretic Peptide (Pro BNP)
  • Idiopathic and Hereditary Pancreatitis
  • Immunohistochemistry for Burkitt lymphoma panel CD20, CD10, BCL-6, BCL-2, Ki-67
  • Syphilis, latent
  • Hereditary Angioedema Diagnostic Panel
  • Coccidioides Antibody, IgM
  • Listeria Antibody, Serum
  • Soluble Fibrin Monomer
  • Actinomyces Culture
  • LDS
  • Sign up
  • Log in
  • LDS
  • /Medical Tests
  • /Duchenne/Becker Muscular Dystrophy (DMD) Gene Mutation Analysis
  • All
  • Diseases
  • Overview
  • Clinical Utility
  • Interpretation
  • Reference Ranges
  • Methodology
  • Specimen Collection
  • Additional Testing
  • Turnaround Time
  • CPT
  • LOINC
  • ICD10
  • Additional ICD10
  • References
  • All
  • Diseases
  • Overview
  • Clinical Utility
  • Interpretation
  • Reference Ranges
  • Methodology
  • Specimen Collection
  • Additional Testing
  • Turnaround Time
  • CPT
  • LOINC
  • ICD10
  • Additional ICD10
  • References

Duchenne/Becker Muscular Dystrophy (DMD) Gene Mutation Analysis
Medical Test

Turnaround Time
Access to Duchenne/Becker Muscular Dystrophy (DMD) Gene Mutation Analysis is restricted.
Loading...